The Most Powerful Detoxifier on Earth - Cleans the Liver, Gut and Brain

DeLauer notes that most people do not consume detoxifying foods like cruciferous vegetables in the morning; it's an odd time. However, moringa can be easily integrated because it's a powder or capsule. He suggests capitalizing on the circadian rhythm of the body's detox pathways, which are already somewhat elevated after the overnight fast. By taking it in the morning, you 'piggyback' on that upregulation, enhancing the overall antioxidant response. This contrasts with typical supplement timing advice that often disregards chronobiology. He also mentions that taking it at the end of a fast is particularly potent, which may be early morning for many intermittent fasters.

DeLauer explains that while fasting is beneficial, it is a stressor that generates free radicals. When you finally eat, the metabolic processing of food adds more oxidative stress. By introducing moringa as you break the fast, you provide a bolus of phase 2 detoxification enzymes and direct antioxidants right when they are most needed. This is a targeting strategy, not just general daily supplementation. He suggests that this practice can make the fast more effective by reducing the collateral damage from the oxidative spike, potentially improving recovery and detox outcomes.

DeLauer draws a direct analogy to his recommendations for methylene blue, a compound he says should not be taken continuously at high doses. He emphasizes that moringa is 'very powerful' and that the body shouldn't become reliant on external antioxidants. High stress periods—travel, marital conflict, fasting—are appropriate times to use a higher dose because the body's defenses are overwhelmed. Conversely, he personally works out a lot, causing regular stress, so a low daily dose is fine for him. The concept is that the dose should scale with the stress demand, and that consistent high dosing could mute the body's own NRF2 response over time. He also mentions that the Morning Being product delivers a convenient low dose for daily use.

DeLauer describes a 'padlock' that normally restricts NRF2 from entering the cell to reach DNA. Moringa unlocks that padlock, allowing NRF2 to flood in. However, even when NRF2 enters, the body deploys KAP1 (Keep One) to tag it for destruction, preventing long-term activation. Moringa disarms KAP1, stopping this tagging, so NRF2 levels remain high. Once in the nucleus, NRF2 binds DNA and triggers phase 2 detoxification enzymes like glutathione and superoxide dismutase, which neutralize rogue electrons and convert superoxide into harmless hydrogen peroxide. This dual action—opening the gate and removing the security—is why DeLauer posits moringa may outshine other NRF2 activators. He contrasts this with sulfurophane, which does activate NRF2 but may not have the same anti-degradation effect, making moringa a more robust intervention for chronic oxidative stress.

DeLauer reviews a cell study where moringa leaf extract applied to macrophages directly suppressed the protein expression of inducible nitric oxide synthase, cyclooxygenase-2, and NF-kB. Additionally, it inhibited secretion of prostaglandin E2, tumor necrosis factor alpha, IL-6, and IL-1beta. By blocking NF-kB movement into the cell, moringa effectively 'turns off inflammation at a very core level,' as he puts it. He then connects this to an animal study where Moringa isothiocyanate reduced LPS-induced inflammation in liver, spleen, colon, and kidneys, demonstrating organ-level protection. Furthermore, he notes evidence that moringa activates anti-inflammatory IL-6, adding a third layer: neutralizing direct inflammation, blocking the master switch, and boosting the body's own anti-inflammatory machinery. This is a contrast to the typical simplistic view of antioxidants just 'mopping up' free radicals, presenting moringa as a multi-target anti-inflammatory agent.

DeLauer explains that the first study examined 'esoteric' markers that may not capture overall inflammatory load, while the second targeted high-sensitivity CRP, a master marker of systemic inflammation. The pivotal factor was the population: the second study enrolled diabetic individuals with metabolic dysfunction. Here, moringa supplementation cut CRP in half, a clinically meaningful drop. He interprets this as evidence that moringa works for everyone, but its measurable impact on inflammation is much larger when the system is already dysregulated. In healthy users, moringa may act more as a maintenance tool, preserving low inflammation rather than causing a dramatic drop. He draws a parallel to methylene blue, which often shows negligible benefits in healthy cohorts. This nuance warns against interpreting null findings in healthy populations as proof of ineffectiveness, and encourages targeted use for those with elevated inflammatory markers.

DeLauer explicitly compares moringa to methylene blue, another powerful compound he suggests using intermittently. He states he doesn't like the body to become dependent on anything. For high-dose moringa, he recommends reserving it for times of extra stress: travel, emotional strain, fasting, caloric restriction, or artificial stressors. However, for individuals who consistently stress their body through intense exercise (like himself), a low daily dose is acceptable because the stress load is constant. This low dose maintains protective levels without overwhelming the system. He mentions that the Morning Being product provides a suitable low-dose daily option. This cycling strategy acknowledges the body's homeostasis mechanisms and prevents the potential blunting of the very NRF2 pathways that moringa activates, promoting a smarter, personalized supplementation regimen.